What does CUSIP 45168K405 represent in this 13F holders report?

CUSIP 45168K405 is the security identifier for IDRA - IDERA PHARMACEUTICALS INC - COM PAR used to aggregate holder disclosures.

How many institutions held IDRA - IDERA PHARMACEUTICALS INC - COM PAR in Q1 2023?

No institutional holders were reported for IDRA - IDERA PHARMACEUTICALS INC - COM PAR in Q1 2023; review adjacent reporting periods for trend context.

IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / COM PAR
Total 13F shares: 0
Share change: -3,232,193
Total reported value: $0
Number of holders: 0
Value change: -$1,129,615
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2022

Recent filing periods for CUSIP 45168K405:

Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

Q1 2023 13F Holders as of 31 Mar 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of IDRA - IDERA PHARMACEUTICALS INC - COM PAR as of Q1 2023.